The Changing Landscape for Stroke?Prevention in AF: Findings From the GLORIA-AF Registry Phase 2
Journal
Journal of the American College of Cardiology
Journal Volume
69
Journal Issue
7
Pages
777-785
Date Issued
2017
Author(s)
Huisman M.V.
Rothman K.J.
Paquette M.
Teutsch C.
Diener H.-C.
Dubner S.J.
Halperin J.L.
Ma C.S.
Zint K.
Elsaesser A.
Bartels D.B.
Lip G.Y.H.
Abban D.
Abdul N.
Abelson M.
Ackermann A.
Adams F.
Adams L.
Adrag?o P.
Ageno W.
Aggarwal R.
Agosti S.
Marin J.A.
Aguilar F.
Aguilar Linares J.A.
Aguinaga L.
Ahmad Z.
Ainsworth P.
Al Ghalayini K.
Al Ismail S.
Alasfar A.
Alawwa A.
Al-Dallow R.
Alderson L.
Alexopoulos D.
Ali A.
Ali M.
Aliyar P.
Al-Joundi T.
Al Mahameed S.
Almassi H.
Almuti K.
Al-Obaidi M.
Alshehri M.
Altmann U.
Alves A.R.
Jr.
Al-Zoebi A.
Amara W.
Amelot M.
Amjadi N.
Ammirati F.
Andrawis N.
Angoulvant D.
Annoni G.
Ansalone G.
Antonescu S.A.
Ariani M.
Arias J.C.
Armero S.
Arora R.
Arora C.
Ashcraft W.
Aslam M.S.
Astesiano A.
Audouin P.
Augenbraun C.
Aydin S.
Azar R.
Azim A.
Aziz S.
Backes L.M.
Baig M.
Bains S.
Bakbak A.
Baker S.
Bakhtiar K.
Bala R.
Banayan J.
Bandh S.
Bando S.
Banerjee S.
Bank A.
Barbarash O.
Bar?n G.
Barr C.
Barrera C.
Barton J.
Kes V.B.
Baula G.
Bayeh H.
Bazargani N.
Behrens S.
Bell A.
Benezet-Mazuecos J.
Benhalima B.
Berdagu? P.
Berg van den B.J.
Bergen van P.F.M.M.
Berngard E.
Bernstein R.
Berrospi P.
Berti S.
Bertomeu V.
Berz A.
Bettencourt P.
Betzu R.
Beyer-Westendorf J.
Bhagwat R.
Black T.
Blanco Ibaceta J.H.
Bloom S.
Blumberg E.
Bo M.
Bockisch V.
B?hmer E.
Bongiorni M.G.
Boriani G.
Bosch R.
Boswijk D.J.
Bott J.
Bottacchi E.
Kalan M.B.
Brandes A.
Bratland B.
Brautigam D.
Breton N.
Brouwers P.J.A.M.
Browne K.
Bruguera J.
Brunehaut M.
Brunschwig C.
Buathier H.
Buhl A.
Bullinga J.
Butcher K.
Cabrera Honorio J.W.
Caccavo A.
Cadinot D.
Cai S.
Calvi V.
Camm J.
Candeias R.
Capo J.
Jr.
Capucci A.
Cardoso J.N.
Duarte Vera Y.C.
Carlson B.
Carvalho P.
Cary S.
Casanova R.
Casu G.
Cattan S.
Cavallini C.
Cayla G.
Cha T.J.
Cha K.S.
Chaaban S.
Chae J.K.
Challappa K.
Chand S.
Chandrashekar H.
Chang M.
Charbel P.
Chartier L.
Chatterjee K.
Cheema A.
Chen S.-A.
Chevallereau P.
Chiarella F.
Chih-Chan L.
Cho Y.K.
Choi D.J.
Chouinard G.
Danny, Chow H.F.
Chrysos D.
Chumakova G.
Jos? Roberto Chuquiure Valenzuela E.J.
Cieza-Lara T.
Nica V.C.
Ciobotaru V.
Cislowski D.
Citerne O.
Claus M.
Clay A.
Clifford P.
Cohen S.
Cohen A.
Colivicchi F.
Collins R.
Compton S.
Connors S.
Conti A.
Buenostro G.C.
Coodley G.
Cooper M.
Corbett L.
Corey O.
Coronel J.
Corrigan J.
Cotrina Pereyra R.Y.
Cottin Y.
Coutu B.
Cracan A.
Crean P.
Crenshaw J.
Crijns H.J.G.M.
Crump C.
Cucher F.
Cudmore D.
Cui L.
Culp J.
Darius H.
Dary P.
Dascotte O.
Dauber I.
Davee T.
Davies R.
Davis G.
Davy J.-M.
Dayer M.
De La Briolle A.
de Mora M.
De Teresa E.
De Wolf L.
Decoulx E.
Deepak S.
Defaye P.
Del-Carpio Munoz F.
Brkljacic D.D.
Deluche L.
Destrac S.
Deumite N.J.
Di Legge S.
Dibon O.
Diemberger I.
Dillinger J.
Dion?sio P.
Naydenov S.
Dotani I.
Dotcheva E.
D'Souza A.
Dubrey S.
Ducrocq X.
Dupljakov D.
DuThinh V.
Dutra O.P.
Dutta D.
Duvilla N.
Dy J.
Dziewas R.
Eaton C.
Eaves W.
Ebinger M.
Eck van J.W.M.
Edwards T.
Egocheaga I.
Ehrlich C.
Eisenberg S.
El Hallak A.
El Jabali A.
El Mahmoud R.
El Shahawy M.
Eldadah Z.
Elghelbazouri F.
Elhag O.
El-Hamdani M.
Elias D.
Ellery A.
El-Sayed H.
Elvan A.
Erickson B.
Espaliat E.
Essandoh L.
Everington T.
Evonich R.
III, Ezhov A.
F?cila L.
Farsad R.
Fayard M.
Fedele F.
Gomes Ferreira L.G.
Ferreira D.
Santos J.F.
Ferrier A.
Finsen A.
First B.
Fisher R.
Floyd J.
Folk T.
Fonseca C.
Fonseca L.
Forman S.
Forsgren M.
Foster M.
Foster N.
Frais M.
Frandsen B.
Frapp? T.
Freixa R.
French W.
Freydlin M.
Frickel S.
Fruntelata A.G.
Fujii S.
Fujino Y.
Fukunaga H.
Furukawa Y.
Gabelmann M.
Gabris M.
Gadsb?ll N.
Galin P.
Galinier M.
Ganim R.
Garcia R.
Quintana A.G.
Gartenlaub O.
Genz C.
Georger F.
Georges J.-L.
Georgeson S.
Ghanbasha A.
Giedrimas E.
Gierba M.
Gillespie E.
Giniger A.
Gkotsis A.
Gmehling J.
Gniot J.
Goethals P.
Goldberg R.
Goldmann B.
Goldscher D.
Golitsyn S.
Gomez Lopez E.A.
Gomez Mesa J.E.
Gonzalez E.
Cocina E.G.
Juanatey C.G.
Gorbunov V.
Gordon B.
Gorka H.
Gornick C.
Gorog D.
Goss F.
G?tte A.
Goube P.
Goudevenos I.
Goulden D.
Graham B.
Grande A.
Greco C.
Green M.
Greer G.
Gremmler U.
Grena P.
Grinshstein Y.
Grond M.
Gronda E.
Grondin F.
Gr?nefeld G.
Groot de J.R.
Guardigli G.
Guarnieri T.
Caiedo C.G.
Guignier A.
Gulizia M.
Gumbley M.
Gupta D.
Hack T.
Haerer W.
Hakas J.
Hall C.
Hampsey J.
Hananis G.
Hanbali B.
Handel F.
Hargrove J.
Hargroves D.
Harris K.
Hartley D.
Haruna T.
Hata Y.
Hayek E.
Healey J.
Hearne S.
Heggelund G.
Hemels M.E.W.
Hemery Y.
Henein S.
Henz B.
Her S.-H.
Hermany P.
Hernandes M.E.
Higashino Y.
Hill M.
Hisadome T.
Hishida E.
Hitchcock J.
Hoffer E.
Hoghton M.
Holmes C.
Hong S.K.
Houppe Nousse M.-P.
Howard V.
Hsu L.F.
Huang C.-H.
Huckins D.
Huehnergarth K.
Huizenga A.
Huntley R.
Hussein G.
Hwang G.-S.
Igbokidi O.
Iglesias I.
Ikpoh M.
Imberti D.
Ince H.
Indolfi C.
Ionova T.
Ip J.
Irles D.
Iseki H.
Ismail Y.
Israel N.
Isserman S.
Iteld B.
Ivanchura G.
Iyer R.
Iyer V.
Iza Villanueva R.O.
Jackson-Voyzey E.
Jaffrani N.
J?ger F.
Jain M.
James M.
Jamon Y.
Jang S.W.
Pereira Jardim C.A.
Jarmukli N.
Jeanfreau R.
Jenkins R.
Jiang X.
Jiang H.
Jiang T.
Jiang N.
Jimenez J.
Jobe R.
Joffe I.
Johansson B.
Jones N.
Moura Jorge J.C.
Jouve B.
Jundi M.
Jung W.
Jung B.C.
Jung K.T.
Kabbani S.
Kabour A.
Kafkala C.
Kajiwara K.
Kalinina L.
Kampus P.
Kanda J.
Kapadia S.
Karim A.
Karolyi L.
Kashou H.
Kastrup A.
Katsivas A.
Kaufman E.
Kawai K.
Kawajiri K.
Kazmierski J.
Keeling P.
Kerfes G.A.
Kerr Saraiva J.F.
Ketova G.
Khaira A.
Khalid M.
Khludeeva E.
Khripun A.
Kim D.I.
Kim D.K.
Kim N.H.
Kim K.S.
Kim Y.-H.
Kim J.B.
Kim J.S.
Kim J.S.
Kinova E.
Klein A.
Kleinschnitz C.
Kmetzo J.
Kneller G.L.
Knezevic A.
Koch S.
Koenig K.
Angela Koh S.M.
K?hrmann M.
Koons J.
Korabathina R.
Korennova O.
Koschutnik M.
Kosinski E.
Kovacic D.
Kowalczyk J.
Koziolova N.
Kragten J.A.
Krause L.U.
Kreidieh I.
Krenning B.J.
Krishnaswamy K.
Krysiak W.
Kuck K.-H.
Kumar S.
K?mler T.
Kuniss M.
Kuo J.-Y.
K?ppers A.
Kurrelmeyer K.
Kwan T.
Kyo E.
Labovitz A.
Lacroix A.
Lam A.
Lanas Zanetti F.T.
Landau C.
Landini G.
Lang W.
Larsen T.B.
Laske V.
Lavandier K.
Law N.
Lee M.H.
Lee D.
Leit?o A.
Lejay D.
Lelonek M.
Lenarczyk R.
Leprince P.
Lequeux B.
Leschke M.
Ley N.
Li Z.
Li Y.
Li X.
Li Z.
Li W.
Liang J.
Lieber I.
Lillestol M.
Limon Rodriguez R.H.
Lin H.
Lip G.
Litchfield J.
Liu Z.
Liu X.
Liu Y.
Liu F.
Liu W.
Llamas Esperon G.A.
Llisterri J.L.
Lo T.
Lo E.
Lobos J.M.
Lodde B.-P.
Loiselet P.
L?pez-Send?n J.
Lorga Filho A.M.
Lori I.
Luo M.
Lupovitch S.
Lyrer P.
Zuhairy H.M.
Ma C.
Ma G.
Ma H.
Madariaga I.
Maeno K.
Magnin D.
Mahmood S.
Mahood K.
Maid G.
Mainigi S.
Makaritsis K.
Maldonado Villalon J.A.
Malhotra R.
Malik A.
Mallecourt C.
Mallik R.
Manning R.
Manolis A.
Mantas I.
Manzur Jattin F.G.
Marcionni N.
Mar?n F.
Santana A.M.
Martinez J.
Martinez L.
Maskova P.
Hern?ndez N.M.
Matskeplishvili S.
Matsuda K.
Mavri A.
May E.
Mayer N.
Mazon P.
McClure J.
McCormack T.
McGarity W.
McGuire M.
McIntyre H.
McLaughlin P.
McLaurin B.
Medina Palomino F.A.
Mehta P.
Mehzad R.
Meinel A.
Melandri F.
Mena A.
Meno H.
Menzies D.
Metcalf K.
Meyer B.
Miarka J.
Mibach F.
Michalski D.
Michel P.
Chreih R.M.
Mikdadi G.
Mikhail M.
Mikus M.
Milicic D.
Militaru C.
Miller G.
Milonas C.
Minescu B.
Mintale I.
Miralles A.
Mirault T.
Mistry D.
Mitchell G.
Miu N.V.
Miyamoto N.
Moccetti T.
Mohammed A.
Nor A.M.
Molina de Salazar D.I.
Molon G.
Molony D.
Mondillo S.
Mont L.
Moodley R.
Moore R.
Ribeiro Moreira D.A.
Mori K.
Moriarty A.
Morka J.
Moschos N.
Mota Gomes M.A.
Mousallem N.
Moya A.
M?gge A.
Mulhearn T.
Muller J.-J.
Muresan C.M.
Muse D.
Musial W.
Musumeci F.
Nadar V.
Nageh T.
Nair P.
Nakagawa H.
Nakamura Y.
Nakayama T.
Nam K.-B.
Napalkov D.
Natarajan I.
Nayak H.
Nechvatal L.
Neiman J.
Nerheim P.
Neuenschwander F.C.
Nishida K.
Nizov A.
Novikova T.
Novo S.
Nowalany-Kozielska E.
Nsah E.
Nunez Fragoso J.C.
Nyvad O.
de Los Rios Ibarra M.O.
O'Donnell M.
O'Donnell P.
Oh D.J.
Oh Y.S.
Daniel Oh C.T.
O'Hara G.
Oikonomou K.
Olalla J.J.
Olivari Z.
Oliver R.
Olympios C.
Osborne J.
Osca J.
Osman R.
Osunkoya A.
Padanilam B.
Panchenko E.
Pandey A.S.
Vicenzo de Paola A.A.
Paraschos A.
Pardell H.
Park H.W.
Park J.S.
Parkash R.
Parker I.
Parrens E.
Parris R.
Passamonti E.
Patel J.
Patel R.
Pentz W.H.
Persic V.
Perticone F.
Peters P.
Petkar S.
Pezo L.F.
Pham D.
Cao Phai G.P.
Phlaum S.
Pineau J.
Pineda-Velez A.
Pini R.
Pinter A.
Pinto F.
Pirelli S.
Pivac N.
Pizzini A.M.
Pocanic D.
Calin Podoleanu C.G.
Polanczyk C.A.
Polasek P.
Poljakovic Z.
Pollock S.
Polo J.
Poock J.
Poppert H.
Porro Y.
Pose A.
Poulain F.
Poulard J.-E.
Pouzar J.
Povolny P.
Pozzer D.
Pras A.
Prasad N.
Prevot S.
Protasov K.
Prunier L.
Puleo J.
Pye M.
Qaddoura F.
Quedillac J.-M.
Raev D.
Rahimi S.
Raisaro A.
Rama B.
Ranadive N.
Randall K.
Ranjith N.
Raposo N.
Rashid H.
Raters C.
Rauch-Kroehnert U.
Rebane T.
Regner S.
Renzi M.
Reyes Rocha M.A.
Reza S.
Ria L.
Richter D.
Rickli H.
Rickner K.
Rieker W.
Rigo F.
Ripoll T.
Fonteles Ritt L.E.
Roberts D.
Pascual C.R.
Briones I.R.
Reyes H.R.
Roelke M.
Roman M.
Romeo F.
Ronner E.
Ronziere T.
Rooyer F.A.
Rosenbaum D.
Roth S.
Rozkova N.
Rubacek M.
Rubalcava F.
Rubanenko O.
Rubin A.
Borret M.R.
Rybak K.
Sabbour H.
Morales O.S.
Sakai T.
Salacata A.
Salecker I.
Salem A.
Salfity M.
Salguero R.
Salvioni A.
Samson M.
Sanchez G.
Sandesara C.
Saporito W.F.
Sasaoka T.
Sattar P.
Savard D.
Scala P.-J.
Scemama J.
Schaupp T.
Schellinger P.
Scherr C.
Schmitz K.-H.
Schmitz B.
Schmitz L.
Schnitzler R.
Schnupp S.
Schoeniger P.
Sch?n N.
Schuster S.
Schwimmbeck P.
Seamark C.
Seebass R.
Seidl K.-H.
Seidman B.
Sek J.
Sekaran L.
Seko Y.
Sepulveda Varela P.A.
Sevilla B.
Shah V.
Shah A.
Shah N.
Shah A.
Shanes J.
Sharareh A.
Sharma V.K.
Shaw L.
Shimizu Y.
Shimomura H.
Shin D.G.
Shin E.-S.
Shite J.
Shoukfeh M.
Shoultz C.
III, Silver F.
Sime I.
Simmers T.A.
Singal D.
Singh N.
Siostrzonek P.
Sirajuddin M.
Skeppholm M.
Smadja D.
Smith R.
Smith D.
Soda H.
Sofley C.W.
Sokal A.
Sotolongo R.
de Souza O.F.
Sparby J.A.
Spinar J.
Sprigings D.
Spyropoulos A.
Stakos D.
Steinberg A.
Steinwender C.
Stergiou G.
Stites H.W.
Stoikov A.
Strasser R.
Streb W.
Styliadis I.
Su G.
Su X.
Suarez R.M.
Sudnik W.
Sueyoshi A.
Sukles K.
Sun L.
Suneja R.
Svensson P.
Ziekenhuis A.
Szavits-Nossan J.
Taggeselle J.
Takagi Y.
Takhar A.
Tallet J.
Tamm A.
Tanaka S.
Tanaka K.
Tang A.
Tang S.
Tassinari T.
Tayama S.
Tayebjee M.
Tebbe U.
Teixeira J.
Tesloianu D.N.
Tessier P.
The S.H.K.
Thevenin J.
Thomas H.
Timsit S.
Topkis R.
Torosoff M.
Touze E.
Traissac T.
Trendafilova E.
Troyan B.
Tsai W.K.
Tse H.F.
Tsutsui H.
Tsutsui T.
Tuininga Y.S.
Turakhia M.
Turk S.
Turner W.
Tveit A.
Twiddy S.
Tytus R.
Ukrainski G.
Valdovinos Chavez S.B.
Van De Graaff E.
Vanacker P.
Vardas P.
Vargas M.
Vassilikos V.
Vazquez J.
Venkataraman A.
Verdecchia P.
Vester E.G.
Vial H.
Vinereanu D.
Vlastaris A.
Vogel C.
vom Dahl J.
von Mering M.
Vora K.
Wakefield P.
Walia J.
Walter T.
Wang M.
Wang N.
Wang F.
Wang X.
Wang Z.
Wang K.-Y.
Watanabe K.
Wei J.
Weimar C.
Weinrich R.
Wen M.-S.
Wheelan K.
Wicke J.
Wiemer M.
Wild B.
Wilke A.
Willems S.
Williams M.
Williams D.
Winkler A.
Wirtz J.H.
Witzenbichler B.
Wong D.H.K.
Lawrence Wong K.S.
Wong B.
Wozakowska-Kaplon B.
Wu Z.
Wu S.
Wyatt N.
Xu Y.
Xu X.
Yamada A.
Yamamoto K.
Yamanoue H.
Yamashita T.
Bryan Yan P.Y.
Yang Y.
Yang T.
Yao J.
Yarlagadda C.
Yeh K.-H.
Yotov Y.
Yvorra S.
Zahn R.
Zamorano J.
Zanini R.
Zarich S.
Zebrack J.
Zenin S.
Zeuthen E.L.
Zhang X.
Zhang Q.
Zhang D.
Zhang D.
Zhang H.
Zhao S.
Zhao X.
Zheng Y.
Zheng Q.
Zhou J.
Zhou J.
Zimmermann S.L.
Zimmermann R.
Zukerman L.S.
Zwaan van der C.
GLORIA-AF Investigators
Abstract
Background GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation at risk of stroke. Phase 2 began when dabigatran, the first non–vitamin K antagonist oral anticoagulant (NOAC), became available. Objectives This study sought to describe phase 2 baseline data and compare these with the pre-NOAC era collected during phase 1. Methods During phase 2, 15,641 consenting patients were enrolled (November 2011 to December 2014); 15,092 were eligible. This pre-specified cross-sectional analysis describes eligible patients’ baseline characteristics. Atrial fibrillation disease characteristics, medical outcomes, and concomitant diseases and medications were collected. Data were analyzed using descriptive statistics. Results Of the total patients, 45.5% were female; median age was 71 (interquartile range: 64, 78) years. Patients were from Europe (47.1%), North America (22.5%), Asia (20.3%), Latin America (6.0%), and the Middle East/Africa (4.0%). Most had high stroke risk (CHA2DS2-VASc [Congestive heart failure, Hypertension, Age ≥75 years, Diabetes mellitus, previous Stroke, Vascular disease, Age 65 to 74 years, Sex category] score ≥2; 86.1%); 13.9% had moderate risk (CHA2DS2-VASc = 1). Overall, 79.9% received oral anticoagulants, of whom 47.6% received NOAC and 32.3% vitamin K antagonists (VKA); 12.1% received antiplatelet agents; 7.8% received no antithrombotic treatment. For comparison, the proportion of phase 1 patients (of N = 1,063 all eligible) prescribed VKA was 32.8%, acetylsalicylic acid 41.7%, and no therapy 20.2%. In Europe in phase 2, treatment with NOAC was more common than VKA (52.3% and 37.8%, respectively); 6.0% of patients received antiplatelet treatment; and 3.8% received no antithrombotic treatment. In North America, 52.1%, 26.2%, and 14.0% of patients received NOAC, VKA, and antiplatelet drugs, respectively; 7.5% received no antithrombotic treatment. NOAC use was less common in Asia (27.7%), where 27.5% of patients received VKA, 25.0% antiplatelet drugs, and 19.8% no antithrombotic treatment. Conclusions The baseline data from GLORIA-AF phase 2 demonstrate that in newly diagnosed nonvalvular atrial fibrillation patients, NOAC have been highly adopted into practice, becoming more frequently prescribed than VKA in Europe and North America. Worldwide, however, a large proportion of patients remain undertreated, particularly in Asia and North America. (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation [GLORIA-AF]; NCT01468701)
SDGs
Type
journal article